Yi-Lan Wang
26Patents
6h-index
35Co-inventors
65Inventor score
Filing activity: Dec 22, 2010 → Jan 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8814025B2 | Fibrin pad matrix with suspended heat activated beads of adhesive | Human Necessities | 1,628 | Active |
| US9393018B2 | Surgical staple assembly with hemostatic feature | Human Necessities | 1,281 | Active |
| US9101359B2 | Surgical staple cartridge with self-dispensing staple buttress | Human Necessities | 890 | Active |
| US8985429B2 | Surgical stapling device with adjunct material application feature | Human Necessities | 806 | Active |
| US8815832B2 | Oxidized regenerated cellulose hemostatic powders and methods of making | Emerging Cross-Sectional Technologies | 20 | Active |
| US10034957B2 | Compacted hemostatic cellulosic aggregates | Human Necessities | 8 | Active |
| US9028851B2 | Hemostatic materials and devices with galvanic particulates | Human Necessities | 5 | Active |
| US9717820B2 | Procoagulant peptides and their derivatives and uses therefor | Human Necessities | 4 | Active |
| US9149511B2 | Procoagulant peptides and their derivatives and uses therefor | Human Necessities | 4 | Active |
| US10183132B2 | Methods and devices for co-delivery of liquid and powdered hemostats and sealants | Human Necessities | 3 | Active |
| US9539358B2 | Oxidized regenerated cellulose hemostatic powders and methods of making | Emerging Cross-Sectional Technologies | 3 | Active |
| US11235085B2 | Compacted hemostatic cellulosic aggregates | Human Necessities | 3 | Active |
| US10456526B2 | Multi-compartment pre-filled mixing syringes with bypass | Human Necessities | 1 | Active |
| US11007299B2 | Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery | Human Necessities | 1 | Active |
| US12377185B2 | Sealant dressing with protected reactive components | Performing Operations; Transporting | 0 | Active |
| US11896732B2 | Compacted hemostatic cellulosic aggregates | Human Necessities | 0 | Active |
| US12385023B2 | CRISPR-Cas system for clostridium genome engineering and recombinant strains produced thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10022410B2 | Hemostatic preparation containing an extract of golden moss | Human Necessities | 0 | Active |
| US12201743B2 | Compacted hemostatic cellulosic aggregates | Human Necessities | 0 | Active |
| US12364785B2 | Expandable hemostat composed of oxidized cellulose | Human Necessities | 0 | Active |
| US11142751B2 | CRISPR-cas system for Clostridium genome engineering and recombinant strains produced thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12415979B2 | Membrane bioreactor for deep-sea cold seeps and online environmental parameter measurement system | Physics | 0 | Active |
| US12285540B2 | Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents | Human Necessities | 0 | Active |
| US11883554B2 | Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery | Human Necessities | 0 | Active |
| US9731076B2 | Multi-compartment pre-filled mixing syringes with bypass | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.